MEI Pharma Inc (MEIP)
3.07
+0.02
(+0.66%)
USD |
NASDAQ |
May 01, 16:00
3.07
0.00 (0.00%)
After-Hours: 18:54
MEI Pharma Net Income (Quarterly): -11.06M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -11.06M |
| September 30, 2023 | 56.37M |
| June 30, 2023 | -10.03M |
| March 31, 2023 | -15.44M |
| December 31, 2022 | 10.25M |
| September 30, 2022 | -16.62M |
| June 30, 2022 | -16.06M |
| March 31, 2022 | -8.725M |
| December 31, 2021 | -12.16M |
| September 30, 2021 | -17.51M |
| June 30, 2021 | -8.378M |
| March 31, 2021 | -25.62M |
| December 31, 2020 | -8.026M |
| September 30, 2020 | 0.712M |
| June 30, 2020 | -19.63M |
| March 31, 2020 | -4.329M |
| December 31, 2019 | -20.22M |
| September 30, 2019 | -2.994M |
| June 30, 2019 | 3.053M |
| March 31, 2019 | -17.36M |
| December 31, 2018 | 12.02M |
| September 30, 2018 | -14.54M |
| June 30, 2018 | -19.25M |
| March 31, 2018 | -5.948M |
| December 31, 2017 | -6.079M |
| Date | Value |
|---|---|
| September 30, 2017 | -8.788M |
| June 30, 2017 | -4.343M |
| March 31, 2017 | -0.602M |
| December 31, 2016 | 11.88M |
| September 30, 2016 | -4.27M |
| June 30, 2016 | -5.77M |
| March 31, 2016 | -5.371M |
| December 31, 2015 | -5.101M |
| September 30, 2015 | -4.62M |
| June 30, 2015 | -5.662M |
| March 31, 2015 | -8.93M |
| December 31, 2014 | -9.109M |
| September 30, 2014 | -8.993M |
| June 30, 2014 | -8.541M |
| March 31, 2014 | -7.387M |
| December 31, 2013 | -6.324M |
| September 30, 2013 | -4.896M |
| June 30, 2013 | -3.215M |
| March 31, 2013 | -2.753M |
| December 31, 2012 | -2.754M |
| September 30, 2012 | -2.464M |
| June 30, 2012 | -2.101M |
| March 31, 2012 | -2.269M |
| December 31, 2011 | -1.541M |
| September 30, 2011 | -1.612M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-25.62M
Minimum
Mar 2021
56.37M
Maximum
Sep 2023
-6.653M
Average
-10.03M
Median
Jun 2023
Net Income (Quarterly) Benchmarks
| Merck & Co Inc | 4.762B |
| United Therapeutics Corp | 217.10M |
| Macrogenics Inc | -46.07M |
| Voyager Therapeutics Inc | 56.40M |
| Moderna Inc | 217.00M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 11.93M |
| EPS Diluted (Quarterly) | -1.66 |
| Enterprise Value | -39.16M |
| Earnings Yield | 96.74% |
| Operating Earnings Yield | 179.6% |
| Normalized Earnings Yield | 199.10 |